Alfredo Carrato

Research interests

Publications

• A faecal microbiota signature with high specificity for pancreatic cancer

  Gut · 2022 · https://doi.org/10.1136/gutjnl-2021-324755

• Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

  Gut · 2019 · https://doi.org/10.1136/gutjnl-2019-319352

• HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

  Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2016.69.4836

• Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations

  Gut · 2017 · https://doi.org/10.1136/gutjnl-2017-314828

• HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology

  Archives of Pathology & Laboratory Medicine · 2016 · https://doi.org/10.5858/arpa.2016-0331-cp

• Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.64.0730

• Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types

  JNCI Journal of the National Cancer Institute · 2015 · https://doi.org/10.1093/jnci/djv279

• A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs

  Journal of Gastrointestinal Cancer · 2015 · https://doi.org/10.1007/s12029-015-9724-1

• Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome

  European Urology · 2013 · https://doi.org/10.1016/j.eururo.2013.08.052

• Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy

  Nature Genetics · 2013 · https://doi.org/10.1038/ng.2799

• A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

  Nature Genetics · 2010 · https://doi.org/10.1038/ng.687

• Polymorphisms in GSTT1 , GSTZ1 , and CYP2E1 , Disinfection By-products, and Risk of Bladder Cancer in Spain

  Environmental Health Perspectives · 2010 · https://doi.org/10.1289/ehp.1002206

• Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study

  The Lancet Oncology · 2008 · https://doi.org/10.1016/s1470-2045(08)70038-x

• Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study

  Clinical Cancer Research · 2007 · https://doi.org/10.1158/1078-0432.ccr-06-2940

• Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

  European Journal of Cancer · 2007 · https://doi.org/10.1016/j.ejca.2007.07.017

• Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

  Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2006.09.8467

• Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas

  Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.05.1771

• Bladder Cancer and Exposure to Water Disinfection By-Products through Ingestion, Bathing, Showering, and Swimming in Pools

  American Journal of Epidemiology · 2006 · https://doi.org/10.1093/aje/kwj364

• Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke, and Gender

  Cancer Epidemiology Biomarkers & Prevention · 2006 · https://doi.org/10.1158/1055-9965.epi-06-0021

• PIK3CA Mutations Are an Early Genetic Alteration Associated with FGFR3 Mutations in Superficial Papillary Bladder Tumors

  Cancer Research · 2006 · https://doi.org/10.1158/0008-5472.can-06-1182

• NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses

  The Lancet · 2005 · https://doi.org/10.1016/s0140-6736(05)67137-1

• Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa043116

• Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage

  Clinical & Translational Oncology · 2005 · https://doi.org/10.1007/bf02712816

• Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group

  Annals of Oncology · 2003 · https://doi.org/10.1093/annonc/mdg260

• Cisplatin Plus Gemcitabine Versus a Cisplatin-Based Triplet Versus Nonplatinum Sequential Doublets in Advanced Non–Small-Cell Lung Cancer: A Spanish Lung Cancer Group Phase III Randomized Trial

  Journal of Clinical Oncology · 2003 · https://doi.org/10.1200/jco.2003.12.038

• Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

  Journal of Clinical Oncology · 1999 · https://doi.org/10.1200/jco.1999.17.1.12

Current projects

No projects listed.